This follows a major move by the U.S. Food and Drug Administration (FDA) in January, under former President Joe Biden, to ban ...

The Trump administration plans to take action to remove artificial food dyes from the nation’s food supply, according to a ...

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Many compounding pharmacies are no longer allowed to make cheaper versions of semaglutide and other GLP-1 drugs. A doctor ...

U.S. health officials plan to phase out eight petroleum-based colors from the nation's food supply. The move would trigger an ...

1,3 Additionally, CAMZYOS is no longer contraindicated with moderate CYP2C19 inhibitors and strong CYP3A4 inhibitors, which were adjusted to drug interactions. This provides physicians with ...

He covers federal public health agencies. The Food and Drug Administration is drawing up plans that would end most of its routine food safety inspections work, multiple federal health officials ...

WASHINGTON, April 17 (Reuters) - The Food and Drug Administration is suspending a quality control program for its food testing laboratories as a result of staff cuts at the Department of Health ...

today announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS® (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules), simplifying treatment ...

This section instructs the Food and Drug Administration (FDA) to “streamline and improve” its existing drug importation program “to make it easier for States to obtain approval without ...

which aren’t subject to negotiation for 13 years after approval by the Food and Drug Administration. By contrast, small molecule drugs, which are generally cheaper and treat more people ...